Skip to main content
. 2022 Jun 13;13(2):169–174. doi: 10.4103/jcvjs.jcvjs_15_22

Table 1.

Comparison between the groups

Total Non-smokers Smokers P
Number of cases 58,304 45,952 (78.8%) 12,352 (21.2%)
Age (years) 62.0 53.6 <0.001*
Male (%) 46.2 45.4 49.3 <0.001*
Anemia (%) 18.2 19.4 13.8 <0.001*
Hypoalbuminemia (%) 2.0 1.9 2.2 0.022
Dependent functional status (%) 2.3 2.3 2.0
Comorbidities
 Diabetes (%) 17.9 19.0 13.8 <0.001*
 Hypertension (%) 57.2 59.7 47.8 <0.001*
 COPD (%) 4.9 3.4 10.4 <0.001*
 Heart failure (%) 0.2 0.2 0.3 0.661
 Chronic steroid use (%) 4.1 4.4 3.1 <0.001*
 Hemodialysis (%) 0.2 0.2 0.3 0.338
BMI 30.9 29.7 <0.001*
Operative time (mean hours) 3.6 3.5 <0.001*
ASA category of 3 or higher (%) 50.7 50.7 50.4 0.442
Average number of levels 1.6 1.5 <0.001*
Transfusions (%) 13.7 14.5 10.8 <0.001*
Complications (%) 6.7 6.9 6.0 <0.001*
Severe complications (%) 1.9 2.0 1.6 0.014*
Discharge to SNIF (%) 10.4 11.5 6.3 <0.001*
Length of stay (days) 3.8 3.5 <0.001*
Mortality (%) 0.2 0.2 0.2 0.809

*shows the P value is significant at p=.05